Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study

BMC Endocr Disord. 2017 May 30;17(1):28. doi: 10.1186/s12902-017-0176-4.

Abstract

Background: The feature of nonalcoholic fatty liver disease (NAFLD) is pathological excessive liver lipid accumulation of subjects who without history of alcohol abuse. Calf circumference is a proxy for lower-body fat and screening method for the identification of subjects with acatastatic lipid accumulation. The objective of this study was to examine the association between calf circumference and NAFLD.

Methods: The study was a cross-sectional analysis including 8850 middle-aged and elderly individuals. NAFLD was examined by hepatic ultrasound and without alcohol abuse and other liver diseases. Calf circumference was measured on the lower right leg at the point of maximal circumference.

Results: The mean of calf circumference were 35.7 cm for male and 34.6 cm for female (P < 0.001), respectively. Compared with the lowest calf circumference quartile, the odds ratio for NAFLD in the highest quartile was 2.73 (95% CI 2.34-3.19, P trend <0.001) after adjusted for potential cofounders. There were also significant positive correlation between calf circumference and HOMA-IR, liver enzyme levels and triglycerides. In addition, we found significant positive correlation of calf circumference with the HOMA-IR and fasting insulin level in overweight and obese subjects (BMI ≥ 24 kg/m2) but not in lean subjects (test for interaction: P both less than 0.001 for insulin and HOMA-IR).

Conclusion: High calf circumference is significantly associated with elevated prevalence of NAFLD and increasing insulin resistance.

Keywords: Calf circumference; Chinese; Insulin resistance; Nonalcoholic fatty liver disease.

MeSH terms

  • Aged
  • Female
  • Humans
  • Insulin Resistance*
  • Leg / anatomy & histology*
  • Lipid Metabolism
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology*